Senator: CDC Wasted Time Early In Pandemic By Insisting On Being Sole COVID-19 Test Developer
Executive Summary
A new report from US Sen. Richard Burr looks at challenges in the country’s public health response to SARS-CoV-2, particularly during the pandemic’s early stages, and recommends ways to better prepare for future pandemics.
You may also be interested in...
FDA Authorizes At-Home COVID-19/Influenza Testing Kits As World Braces For Tough Flu Season
Labcorp’s combined COVID-19 and influenza A/B test has received emergency use approval in a bid to minimize spread of both illnesses during this winter.
Come On In, The Water’s Fine: FDA Should Fully Embrace Remote Inspections
Former US FDA device center compliance chief Steve Silverman argues in this opinion piece that the agency and stakeholders should take steps now to develop a remote-inspection framework for medical device manufacturers.
Experts Ho-Hum About FDA’s First-Ever Device Shortage List
The US agency’s shortage list of critical medical devices needed during the COVID-19 public health emergency has been met with shrugs by two former agency officials, who say the statutorily mandated online listing offers limited value.